Analyst Ratings For NASDAQ:AMED – Amedisys (NASDAQ:AMED)
Today, Stephens reiterated its Hold rating on NASDAQ:AMED – Amedisys (NASDAQ:AMED).
Some recent analyst ratings include
- 6/5/2018-Stephens Reiterated Rating of Hold.
- 3/19/2018-Royal Bank of Canada Upgrade from a “Sector Perform ➝ Outperform” rating to a “” rating.
- 11/21/2017-William Blair Reiterated Rating of Outperform.
Recent Insider Trading Activity For NASDAQ:AMED – Amedisys (NASDAQ:AMED)
NASDAQ:AMED – Amedisys (NASDAQ:AMED) has insider ownership of 2.60% and institutional ownership of 93.85%.
- On 5/11/2018 Michael Paul North, Insider, sold 11,000 with an average share price of $71.52 per share and the total transaction amounting to $786,720.00.
- On 8/8/2017 David B Pearce, Insider, sold 1,000 with an average share price of $50.00 per share and the total transaction amounting to $50,000.00.
- On 8/3/2017 Bruce D Perkins, Director, bought 2,000 with an average share price of $46.60 per share and the total transaction amounting to $93,200.00.
- On 5/25/2017 Bruce D Perkins, Director, bought 500 with an average share price of $59.69 per share and the total transaction amounting to $29,845.00.
- On 5/12/2017 Jake L Netterville, Director, sold 10,000 with an average share price of $60.00 per share and the total transaction amounting to $600,000.00.
- On 5/10/2017 Lawrence R Pernosky, Insider, sold 11,500 with an average share price of $58.97 per share and the total transaction amounting to $678,155.00.
- On 5/9/2017 Lawrence R Pernosky, Insider, sold 11,500 with an average share price of $58.78 per share and the total transaction amounting to $675,970.00.
Recent Trading Activity for NASDAQ:AMED – Amedisys (NASDAQ:AMED)
Shares of NASDAQ:AMED – Amedisys closed the previous trading session at 79.80 up +2.76 3.58% with shares trading hands.